{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:57:43Z","timestamp":1794473863569,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":39,"publisher":"Springer New York","isbn-type":[{"value":"9781493904099","type":"print"},{"value":"9781493904105","type":"electronic"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1007\/978-1-4939-0410-5_16","type":"book-chapter","created":{"date-parts":[[2014,4,8]],"date-time":"2014-04-08T06:19:29Z","timestamp":1396937969000},"page":"259-281","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Immunotherapy for Alzheimer\u2019s Disease: DNA- and Protein-Based Epitope Vaccines"],"prefix":"10.1007","author":[{"given":"Hayk","family":"Davtyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Petrushina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahit","family":"Ghochikyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,5]]},"reference":[{"key":"16_CR1","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1146\/annurev.med.45.1.435","volume":"45","author":"DL Price","year":"1994","unstructured":"Price DL, Sisodia SS (1994) Cellular and molecular biology of Alzheimer's disease and animal models. Annu Rev Med 45:435\u2013446","journal-title":"Annu Rev Med"},{"key":"16_CR2","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","volume":"6","author":"DJ Selkoe","year":"1991","unstructured":"Selkoe DJ (1991) The molecular pathology of Alzheimer's disease. Neuron 6:487\u2013498","journal-title":"Neuron"},{"key":"16_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256:184\u2013185","journal-title":"Science"},{"key":"16_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"DJ Schenk","year":"1999","unstructured":"Schenk DJ, Barbour R, Dunn W et al (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173\u2013177","journal-title":"Nature"},{"key":"16_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan D, Diamond DM, Gottschall PE et al (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982\u2013985","journal-title":"Nature"},{"key":"16_CR6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard F, Cannon C, Barbour R (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916\u2013919","journal-title":"Nat Med"},{"key":"16_CR7","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1073\/pnas.151261398","volume":"98","author":"RB DeMattos","year":"2001","unstructured":"DeMattos RB, Bales KR, Cummins DJ (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 98:8850\u20138855","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","volume":"5","author":"JC Dodart","year":"2002","unstructured":"Dodart JC, Bales KR, Gannon KS et al (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5:452\u2013457","journal-title":"Nat Neurosci"},{"key":"16_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm840","volume":"9","author":"JA Nicoll","year":"2003","unstructured":"Nicoll JA, Wilkinson D, Holmes C et al (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 9:448\u2013452","journal-title":"Nat Med"},{"key":"16_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","volume":"14","author":"I Ferrer","year":"2004","unstructured":"Ferrer I, Rovira MB, Guerra MLS et al (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 14:11\u201320","journal-title":"Brain Pathol."},{"key":"16_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","volume":"64","author":"E Masliah","year":"2005","unstructured":"Masliah E, Hansen L, Adame A et al (2005) Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64:129\u2013131","journal-title":"Neurology"},{"key":"16_CR12","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","volume":"65","author":"JA Nicoll","year":"2006","unstructured":"Nicoll JA, Barton E, Boche D et al (2006) Abeta species removal after abeta42 immunization. J Neuropathol Exp Neurol 65:1040\u20131048","journal-title":"J Neuropathol Exp Neurol"},{"key":"16_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","volume":"169","author":"RL Patton","year":"2006","unstructured":"Patton RL, Kalback WM, Esh CL (2006) Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis. Am J Pathol 169:1048\u20131063","journal-title":"Am J Pathol"},{"key":"16_CR14","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D et al (2008) Long-term effects of Abeta42 immunization in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372: 216\u2013223","journal-title":"Lancet"},{"key":"16_CR15","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","volume":"64","author":"S Gilman","year":"2005","unstructured":"Gilman S, Koller M, Black RS et al (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64:1553\u20131562","journal-title":"Neurology"},{"key":"16_CR16","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","volume":"64","author":"AJ Bayer","year":"2005","unstructured":"Bayer AJ, Bullock R, Jones RW et al (2005) Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD. Neurology 64:94\u2013101","journal-title":"Neurology"},{"key":"16_CR17","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/intimm\/dxg049","volume":"15","author":"DH Cribbs","year":"2003","unstructured":"Cribbs DH, Ghochikyan A, Tran M et al (2003) Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int Immunol 15:505\u2013514","journal-title":"Int Immunol"},{"key":"16_CR18","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1073\/pnas.0436286100","volume":"100","author":"F Bard","year":"2003","unstructured":"Bard F, Barbour R, Cannon C et al (2003) Epitope and isotype specificities of antibodies to beta -amyloid peptide for protection against Alzheimer's disease-like neuropathology. Proc Natl Acad Sci U S A 100:2023\u20132028","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16_CR19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ana.20592","volume":"58","author":"M Lee","year":"2005","unstructured":"Lee M, Bard F, Johnson-Wood K (2005) Abeta42 immunization in Alzheimer's disease generates Abeta N-terminal antibodies. Ann Neurol 58:430\u2013435","journal-title":"Ann Neurol"},{"key":"16_CR20","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nm790","volume":"8","author":"J McLaurin","year":"2002","unstructured":"McLaurin J, Cecal R, Kierstead ME et al (2002) Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4\u201310 and inhibit cytotoxicity and fibrillogenesis. Nat Med 8:1263\u20131269","journal-title":"Nat Med"},{"key":"16_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/S0304-3940(01)01951-6","volume":"307","author":"T Town","year":"2001","unstructured":"Town T, Tan J, Sansone N et al (2001) Characterization of murine immunoglobulin G antibodies against human amyloid-b 1\u201342. Neurosci Lett 307:101\u2013104","journal-title":"Neurosci Lett"},{"issue":"11","key":"16_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1089\/10445490152717587","volume":"20","author":"CA Dickey","year":"2001","unstructured":"Dickey CA, Morgan DG, Kudchodkar S et al (2001) Duration and specificity of humoral immune responses in mice vaccinated with the Alzheimer's disease-associated beta-amyloid 1\u201342 peptide. DNA Cell Biol 20(11):723\u2013729","journal-title":"DNA Cell Biol."},{"key":"16_CR23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1089\/10445490152717569","volume":"20","author":"CA Lemere","year":"2001","unstructured":"Lemere CA, Maron R, Selkoe DJ et al (2001) Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer's disease. DNA Cell Biol 20:705\u2013711","journal-title":"DNA Cell Biol."},{"key":"16_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1749-6632.2000.tb06943.x","volume":"920","author":"CA Lemere","year":"2000","unstructured":"Lemere CA, Maron R, Spooner ET et al (2000) Nasal A\u00df treatment induces anti-A\u00df antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann N Y Acad Sci 920:328\u2013331","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"16_CR25","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1172\/JCI200318104","volume":"112","author":"A Monsonego","year":"2003","unstructured":"Monsonego A, Zota V, Karni A (2003) Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J Clin Invest 112(3):415\u2013422","journal-title":"J Clin Invest"},{"key":"16_CR26","doi-asserted-by":"publisher","first-page":"6277","DOI":"10.1523\/JNEUROSCI.1344-04.2004","volume":"24","author":"EM Sigurdsson","year":"2004","unstructured":"Sigurdsson EM, Knudsen E, Asuni A et al (2004) An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives. J Neurosci 24:6277\u20136282","journal-title":"J Neurosci"},{"key":"16_CR27","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1093\/bioinformatics\/17.12.1236","volume":"17","author":"H Singh","year":"2001","unstructured":"Singh H, Raghava GP (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236\u20131237","journal-title":"Bioinformatics"},{"key":"16_CR28","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1093\/bioinformatics\/btg108","volume":"19","author":"H Singh","year":"2003","unstructured":"Singh H, Raghava GP (2003) ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19:1009\u20131014","journal-title":"Bioinformatics"},{"key":"16_CR29","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/S0197-4580(03)00036-8","volume":"24","author":"P Das","year":"2003","unstructured":"Das P, Chapoval S, Howard V et al (2003) Immune responses against Abeta1-42 in HLA class II transgenic mice: implications for Abeta1-42 immune-mediated therapies. Neurobiol Aging 24:969\u2013996","journal-title":"Neurobiol Aging"},{"key":"16_CR30","doi-asserted-by":"publisher","first-page":"12721","DOI":"10.1523\/JNEUROSCI.3201-07.2007","volume":"27","author":"I Petrushina","year":"2007","unstructured":"Petrushina I, Ghochikyan A, Mktrichyan M et al (2007) Alzheimer's disease peptide epitope vaccine reduces insoluble but not soluble\/oligomeric A{beta} species in amyloid precursor protein transgenic mice. J Neurosci 27:12721\u201312731","journal-title":"J Neurosci"},{"key":"16_CR31","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1371\/journal.pone.0002124","volume":"3","author":"N Movsesyan","year":"2008","unstructured":"Movsesyan N, Ghochikyan A, Mkrtichyan M et al (2008) Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine- a novel immunotherapeutic strategy. PLos One 3:e21","journal-title":"PLos One"},{"key":"16_CR32","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4161\/hv.23875","volume":"9","author":"A Ghochikyan","year":"2013","unstructured":"Ghochikyan A, Davtyan H, Petrushina I et al (2013) Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits. Hum Vaccin Immunother 9:1002\u20131010","journal-title":"Hum Vaccin Immunother"},{"key":"16_CR33","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1523\/JNEUROSCI.4672-12.2013","volume":"33","author":"H Davtyan","year":"2013","unstructured":"Davtyan H, Ghochikyan A, Petrushina I et al (2013) Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial. J Neurosci 33:4923\u20134934","journal-title":"J Neurosci"},{"key":"16_CR34","doi-asserted-by":"crossref","unstructured":"Evans CF, Davtyan H, Petrushina I et al (2013) Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques. Alzheimer\u2019s Dement. [Epub ahead of print]","DOI":"10.1016\/j.jalz.2013.04.505"},{"key":"16_CR35","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.164.3.1625","volume":"164","author":"J Alexander","year":"2000","unstructured":"Alexander J, del Guercio MF, Maewal A (2000) Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses. J Immunol 164:1625\u20131633","journal-title":"J Immunol"},{"key":"16_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/187152709787847298","volume":"8","author":"A Ghochikyan","year":"2009","unstructured":"Ghochikyan A (2009) Rationale for peptide and DNA based epitope vaccines for Alzheimer's disease immunotherapy. CNS Neurol Disord Drug Targets 8:128\u2013143","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"16_CR37","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0264-410X(02)00574-1","volume":"21","author":"LA Babiuk","year":"2003","unstructured":"Babiuk LA, Pontarollo R, Babiuk S et al (2003) Induction of immune responses by DNA vaccines in large animals. Vaccine 21:649\u2013658","journal-title":"Vaccine"},{"key":"16_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1007\/s00114-001-0270-2","volume":"88","author":"JP Gregersen","year":"2001","unstructured":"Gregersen JP (2001) DNA vaccines. Naturwissenschaften 88:504\u2013513","journal-title":"Naturwissenschaften"},{"key":"16_CR39","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/1573395054065179","volume":"1","author":"DH Cribbs","year":"2005","unstructured":"Cribbs DH, Agadjanyan MG (2005) Immunotherapy for Alzheimer's disease: potential problems and possible solutions. Curr Immunol Rev 1:139\u2013155","journal-title":"Curr Immunol Rev"}],"container-title":["Methods in Molecular Biology","DNA Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-0410-5_16","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T10:29:47Z","timestamp":1676370587000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-0410-5_16"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9781493904099","9781493904105"],"references-count":39,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-0410-5_16","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4939-0410-5","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"5 March 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}